Clinical trial
ACCESS: Prospective, Multi-center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis
NCT00260728 is registered in ClinicalTrials.gov with Maquet Cardiovascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ACCESS: Prospective, Multi-center Trial of the Fusion Vascular Access Graft for Patients Who Require Early Vascular Access for Hemodialysis
- Lead sponsor
- Maquet Cardiovascular
- Phase
- Phase 2/3
- Overall status
- Terminated
- Start date
- December 31, 2005
- Completion date
- December 31, 2008
- Enrollment
- 149 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
kidney failure, renal disease